Clinical Trials
Study Title:
A Phase III Clinical Trial Evaluating Deescalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2 Negative, Oncotype Recurrence Score = 18
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Principal Investigator, Harriet Eldredge-Hindy, at eldredge@musc.edu.
Study Coordinator, Talia Everett, at everettt@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |